Foley Partner Louis Lehot Quoted in Crunchbase Discussing First Quarter M&A Activity

Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.

Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.

Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.